Table 2.

Pre-Week 44 Oral Food Challenge Dosing Symptom Summary

Placebo
Visit Type	# Doses	%Symptom Free	%Symptom Free excluding oral/phary	% Oral/Phary Symptoms	% Skin	% Resp.	% GI	% Other	% Symptoms > .5 Hour	% Treated	% Mild	% Moderate	% Severe
Escalation	469	96.38	98.93	2.77	0.43	0.85	0.00	0.43	0.21	0.00	1.07	0.00	0.00
Clinic	130	100.00	100.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Home	5433	99.65	99.78	0.18	0.02	0.02	0.02	0.17	0.07	0.06	0.20	0.02	0.00
All	6032	99.40	99.72	0.38	0.05	0.08	0.02	0.18	0.08	0.05	0.27	0.02	0.00
Peanut SLIT
Visit Type	# Doses	%Symptom Free	%Symptom Free excluding oral/phary	% Oral/Phary Symptoms	% Skin	% Resp.	% GI	% Other	% Symptoms > .5 Hour	% Treated	% Mild	% Moderate	% Severe
Escalation	471	75.37	92.14	21.87	2.12	4.03	1.27	1.06	2.34	1.91	7.64	0.21	0.00
Clinic	143	63.64	95.10	33.57	2.80	1.40	0.00	1.40	2.10	0.00	4.90	0.00	0.00
Home	5211	58.47	94.95	38.76	1.29	2.00	0.90	1.65	1.27	2.21	4.99	0.06	0.00
All	5825	59.97	94.73	37.27	1.39	2.15	0.91	1.60	1.37	2.13	5.20	0.07	0.00
Crossover High Dose
Visit Type	# Doses	%Symptom Free	%Symptom Free excluding oral/phary	% Oral/Phary Symptoms	% Skin	% Resp.	% GI	% Other	% Symptoms > .5 Hour	% Treated	% Mild	% Moderate	% Severe
Escalation	474	74.47	93.88	23.84	0.63	3.80	0.63	1.27	0.42	1.69	5.91	0.21	0.00
Clinic	61	75.41	96.72	24.59	0.00	0.00	1.64	1.64	1.64	0.00	3.28	0.00	0.00
Home	4495	65.72	96.00	32.28	0.71	0.27	0.67	2.51	0.53	3.09	3.98	0.02	0.00
All	5030	66.66	95.81	31.39	0.70	0.60	0.68	2.39	0.54	2.92	4.16	0.04	0.00